Definition
Misbranded describes a product — most commonly a food, drug, cosmetic, or device — whose labeling contains false, misleading, or incomplete information in violation of applicable regulatory law. A misbranded article is not necessarily adulterated or unsafe; the violation is in how the product is represented, not necessarily in what it contains.
Under the foundational federal framework established by the Food and Drugs Act of 1906 and substantially expanded by the Federal Food, Drug, and Cosmetic Act of 1938 (FDCA), a product is misbranded when its label:
1. Bears false or misleading statements about the identity, nature, strength, quality, or purity of the article;
2. Omits required disclosures (such as ingredient listings, quantity of contents, or manufacturer identification);
3. Makes false claims about therapeutic or curative properties; or
4. Fails to carry mandatory warnings or directions for use.
The concept applies across product categories. A food is misbranded if its label falsely describes its ingredients or weight. A drug is misbranded if its labeling makes unsupported efficacy claims or omits required safety information. A device is misbranded if it lacks adequate directions for use. The prohibited conduct is in the representation — the disconnect between the label and the truth.
---
Common Language
Modern common usage (Wiktionary): Simple past and past participle of "misbrand" — to label incorrectly or deceptively.
Historical common usage (Webster's 1913): Not separately defined; the component terms suggest labeling under a wrong or false brand or name.
The ordinary meaning tracks the legal meaning more closely than most regulatory terms do. The critical gap is scope: in common use, "misbranded" suggests deliberate fraud or counterfeit branding. In law, misbranding is a strict liability offense in many contexts — intent is not required to establish a violation. A manufacturer can misbrand a product through negligence, oversight, or regulatory non-compliance without any fraudulent purpose, and still face civil or criminal liability.
---
Common Confusion
Misbranded is frequently conflated with adulterated. These are distinct regulatory violations. Adulteration concerns what a product contains — a substance is adulterated if it includes harmful, filthy, or deceptive ingredients, or if it falls below required purity standards. Misbranding concerns how a product is represented — a substance is misbranded if its label is false or misleading, regardless of whether the product itself is safe and pure. A product can be adulterated without being misbranded (unsafe contents, accurate label) or misbranded without being adulterated (pure contents, false label). Most regulatory statutes address both independently, and enforcement actions may charge one, the other, or both.
---
Why It Matters in Research
The meaning of misbranded has a specific historical boundary that Bouvier identifies and that researchers must hold in mind: under the 1906 Act, misbranding targeted false statements about the identity of an article — its strength, quality, purity — and explicitly did not reach claims about curative or therapeutic effect. That limitation was litigated directly and confirmed in United States v. Johnson, 221 U.S. 488 (1911), which held that false therapeutic claims fell outside the misbranding prohibition as then written. Congress responded by passing the Sherley Amendment in 1912, which extended misbranding to false curative claims made with fraudulent intent. The 1938 FDCA went further still, removing the intent requirement for drug labeling claims and dramatically broadening what constitutes misbranding.
This progression means that the word misbranded does not mean the same thing across time. A pre-1912 source using the term operates under a narrower definition that excludes therapeutic claims. A post-1938 source operates under a much broader strict-liability framework. Researchers working with early twentieth-century administrative records, agency decisions, or treatises must identify which statutory generation is in play before assuming the modern definition applies.
Jurisdictional layering also matters. Federal law establishes a floor, but states have their own misbranding statutes governing products sold intrastate, and these vary in scope, enforcement mechanisms, and definitions. State agricultural and pharmacy codes often use misbranding language that predates federal equivalents and may carry different technical meanings.
For researchers tracing enforcement history, misbranding cases in the early federal period are heavily concentrated in food and patent medicine contexts. The patent medicine industry's resistance to the 1906 Act is a significant backdrop to how courts interpreted the statute narrowly — the Johnson decision reflects that interpretive climate. Post-1938 cases reflect a more expansive regulatory posture and are better entry points for understanding modern doctrine.
---
Historical Dictionary Support
Bouvier's Law Dictionary provides a precise and useful entry that maps directly onto the Johnson decision. Bouvier correctly identifies that the 1906 Act's misbranding provisions were aimed at false statements about identity — strength, quality, purity — and not at curative claims. This is accurate as a description of the law as it stood at the time Bouvier was writing, and the citation to 221 U.S. 488 anchors it to the controlling authority.
What Bouvier does not address — because it postdates his primary editions — is the subsequent statutory evolution through the Sherley Amendment and the 1938 FDCA. The entry is therefore a reliable but frozen snapshot. It is valuable for dating the narrower definition and for understanding the interpretive baseline, but it cannot be read as a statement of continuing law.
No other historical dictionary in the Law Mind corpus provides a competing or supplementary definition of misbranded. The term is largely absent from general common law dictionaries, reflecting its origin as a creature of statute rather than judicial development. Black's Law Dictionary in later editions provides more modern treatments aligned with the FDCA framework.
---
Jurisdictional Note
Federal misbranding law under the FDCA governs products in interstate commerce and is enforced by the FDA. States retain authority over purely intrastate commerce, and most states have adopted analogous misbranding statutes, often modeled on the federal framework but with independent enforcement. Some states impose stricter labeling requirements — particularly for dietary supplements, agricultural products, and cannabis-derived goods — that create misbranding exposure under state law even for products compliant with federal standards.
---